4DX — 4DMedical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$2.44bn
- AU$2.18bn
- AU$7.06m
Annual cashflow statement for 4DMedical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -4.4 | -4.18 | -2.66 | -6 | -3.91 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -25.3 | -22.7 | -30.9 | -34.5 | -31.3 |
| Capital Expenditures | -3.5 | -1.61 | -1.17 | -1.35 | -2.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | -38.9 | -0.275 | -0.025 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.5 | -1.61 | -40 | -1.62 | -2.43 |
| Financing Cash Flow Items | 0 | -1.19 | -2.05 | -1.36 | -13.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.995 | 42.7 | 31.9 | 12.4 | 305 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -29.8 | 18.5 | -39 | -23.7 | 271 |